US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 13, 2022 (4 years ago)

EPI-PEN 2-PAK (epinephrine injection, USP), Single-Dose Auto-Injectors 0.3 mg, Rx only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP deviations: Temperature abuse

What was recalled

EPI-PEN 2-PAK (epinephrine injection, USP), Single-Dose Auto-Injectors 0.3 mg, Rx only, Manufactured for: Mylan Specialty LP., NDC 49502-500-02

Recalling firm
Mckesson Medical-Surgical Inc. Corporate Office
NDC code
49502-500-02
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0993-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Epinephrine recalls

See all